Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Diego, CA
NPI
1215251822
Since 2010
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
6
Medicare group memberships
Hospitals
5
Hospital affiliations
5555 Reservoir Dr, Ste 312
San Diego, CA, 92120
Phone (619) 269-1296
Groups this clinician bills Medicare through
Medicare paid, 2024
$407K
4,971 services
Medicare patients, 2024
1,166
Average age 76
Drug cost, 2024
$6.0M
10,135 prescriptions
Company payments, 2025
$1,265
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farhad Farjoudi was code 99232 (hospital e&m - subsequent), 2,929 times for 481 patients. In total Farhad Farjoudi billed 4,971 services in 20 codes, and Medicare paid $407K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 2,929 | 481 | $63.52 | $186K |
| 99214 Office E&M - Established | Office | 556 | 337 | $99.64 | $55K |
| 99223 Hospital E&M - Initial | Facility | 515 | 469 | $138.90 | $72K |
| 99215 Office E&M - Established | Office | 290 | 176 | $132.02 | $38K |
| 99233 Hospital E&M - Subsequent | Facility | 257 | 76 | $95.76 | $25K |
| 99497 Care Management/Coordination | Facility | 132 | 128 | $61.19 | $8,077 |
| 95251 Test - Miscellaneous | Office | 106 | 70 | $28.73 | $3,045 |
| 99222 Hospital E&M - Initial | Facility | 78 | 74 | $105.64 | $8,240 |
| 99204 Office E&M - New | Office | 57 | 57 | $126.61 | $7,217 |
| 99205 Office E&M - New | Office | 19 | 19 | $140.70 | $2,673 |
By year: 2022 $367K for 4,903 services; 2023 $415K for 5,435 services; 2024 $407K for 4,971 services.
Medicare prescription drug claims, 2024
In 2024, the drug Farhad Farjoudi prescribed most often to Medicare patients was Ozempic (Semaglutide), with 1,165 prescriptions and refills. In total Farhad Farjoudi wrote 10,135 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 1,165 | 1,952 | 273 | $1.8M |
| Levothyroxine Sodium Generic | 853 | 2,366 | 299 | $10K |
| Trulicity Dulaglutide | 736 | 1,202 | 172 | $1.2M |
| Metformin Hcl Generic | 706 | 1,957 | 287 | $6,132 |
| Pioglitazone Hcl Generic | 453 | 1,312 | 170 | $7,849 |
| Mounjaro Tirzepatide | 435 | 660 | 101 | $686K |
| Jardiance Empagliflozin | 374 | 824 | 115 | $478K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 354 | 846 | 129 | $52K |
| Glipizide Generic | 325 | 914 | 130 | $3,065 |
| Synthroid Levothyroxine Sodium | 320 | 835 | 96 | $32K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 258 | 635 | 113 | $22K |
| Metformin Hcl Er Metformin Hcl | 256 | 667 | 84 | $4,152 |
| Atorvastatin Calcium Generic | 210 | 609 | 80 | $1,990 |
| Humalog Kwikpen U-100 Insulin Lispro | 204 | 481 | 70 | $52K |
| Prolia Denosumab | 165 | 874 | 100 | $282K |
Brand drugs: 5,255 claims; generic drugs: 4,320 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farhad Farjoudi $1,265 ($1,265 in general payments such as food, travel and fees) from 22 companies. The largest payer was Amgen Inc. with $199.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.